Canada markets open in 7 hours 22 minutes

Small Pharma Inc. (DMT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.5600-0.0400 (-6.67%)
At close: 3:59PM EDT

Small Pharma Inc.

6-8 Bonhill Street
3rd Floor
London EC2A 4BX
United Kingdom
44 2071 129118
http://www.smallpharma.co.uk

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees13

Key Executives

NameTitlePayExercisedYear Born
Mr. Peter David RandsCEO & Founder135.64kN/AN/A
Mr. David SteelChief Financial Officer20.12kN/AN/A
Ms. Marie Claire LayzellCOO & Head of CMC128.47kN/AN/A
Dr. Carol RoutledgeChief Scientific & Medical Officer128.47kN/AN/A
Mr. George TzirasChief Bus. Officer51.62kN/AN/A
Ms. Nina Kumari M.D.Head of Bus. Devel.N/AN/AN/A
Ms. Ellen James Ph.D.Head of R&DN/AN/AN/A
Mr. Richard M. KimelCorp. Sec.N/AN/A1967
Mr. Jim RennieDirector of Devel. and Member of Scientific & Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Small Pharma Inc., a clinical stage neuropharmaceutical company, engages in the IP-led development of novel treatments for depression and other mental health conditions. The company's lead product candidate is SPL026, a N,N-dimethyltryptamine (DMT) assisted therapy that is in Phase I/IIa randomized controlled clinical trial for the treatment of major depressive disorders. Its preclinical product candidates include SPL028 and SPL029 tryptamine analogues to assess and deliver alternative treatment profiles for the treatment of depression and other mental health disorders; and SPL801, an oral formulation of 6 -hydroxynorketamine. The company was founded in 2015 and is headquartered in London, United Kingdom.

Corporate Governance

Small Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.